Главная
Study mode:
on
1
Introduction
2
LPA
3
Primary prevention
4
HDL vs LDL
5
CCS guidelines
6
Atherosclerosis
7
Guidelines
8
Lowering LDL
9
Inhibitors
10
Statins
11
PCSK9 inhibitors
12
Intravascular Ultrasound
13
Sirna
14
Orion Knife
15
Overall results
16
Safety data
17
Cardiovascular outcome data
18
Where do we stand in Canada
19
How do you do this
20
LDL
21
Hyper Triglyceridemia
22
Guidelines Recommendations
23
Study Results
24
EPA vs DHA
25
Culture
26
Colchicine
27
Antiinflammatory
28
Methotrexate
29
Solidoko
30
Lowdose Colchicine
31
In Circulation
Description:
Learn about the latest developments in cardiovascular disease prevention through a comprehensive cardiology rounds lecture delivered by Dr. Ruth McPherson, a distinguished expert holding the Merck Frosst Canada Chair in Atherosclerosis Research. Explore both established and emerging therapies for dyslipidemia, covering crucial topics including LPA, primary prevention strategies, and the relationship between HDL and LDL cholesterol. Gain insights into CCS guidelines, atherosclerosis management, and various treatment approaches including statins, PCSK9 inhibitors, and intravascular ultrasound techniques. Examine the latest research on hypertriglyceridemia, EPA vs DHA effectiveness, and the role of anti-inflammatory treatments such as colchicine and methotrexate in cardiovascular care. Understand current Canadian treatment protocols and practical implementation strategies for managing lipid disorders in clinical practice.

Dyslipidemia - New and Old Therapies for Cardiovascular Disease Prevention

University of Ottawa Heart Institute
Add to list
0:00 / 0:00